Clinical Trial Design GuideSAFE
🔬 A curated collection of 23,000+ agent skills for empirical research across 8 social science disciplines. | 精选 23,000+ AI Agent 技能库,覆盖8大社会科学学科的实证研究。CoPaper.AI 20分钟完成一篇可复现的规范实证论文,并支持用户上传 Skills。-- Maintained by CoPaper.AI from Stanford REAP.
Overview
🔬 A curated collection of 23,000+ agent skills for empirical research across 8 social science disciplines. | 精选 23,000+ AI Agent 技能库,覆盖8大社会科学学科的实证研究。CoPaper.AI 20分钟完成一篇可复现的规范实证论文,并支持用户上传 Skills。-- Maintained by CoPaper.AI from Stanford REAP.
e1ba289846fdOBSERVED · 2026-10-08Host compatibility
What the documentation claims. We have not run a compatibility test.
| Host | Status | Notes |
|---|---|---|
| openclaw | mentioned |
What it tells the agent
The instruction file, verbatim from the audited commit — this is the text the model reads, and the surface the audit's instruction layer examines. Quoted here so you can judge it without cloning anything.
---
name: clinical-trial-design-guide
description: "Clinical trial methodology, biostatistics, and study design guidance"
metadata:
openclaw:
emoji: "🧪"
category: "domains"
subcategory: "pharma"
keywords: ["clinical-trial", "biostatistics", "randomization", "sample-size", "survival-analysis", "rct"]
source: "wentor"
---
# Clinical Trial Design Guide
A skill for designing and analyzing clinical trials, covering study design selection, sample size calculation, randomization methods, interim analysis, survival endpoints, and regulatory considerations. Essential for pharmaceutical researchers, biostatisticians, and clinical scientists.
## Clinical Trial Phases
### Phase Overview
| Phase | Objective | Typical N | Duration | Primary Endpoints |
|-------|-----------|----------|----------|-------------------|
| Phase I | Safety, dose-finding | 20-80 | Months | MTD, DLT, PK profile |
| Phase II | Efficacy signal, dosing | 100-300 | 1-2 years | Response rate, biomarker |
| Phase III | Confirmatory efficacy | 300-3,000+ | 2-4 years | OS, PFS, clinical outcome |
| Phase IV | Post-marketing surveillance | 1,000+ | Ongoing | Safety, real-world effectiveness |
## Study Design Selection
### Common Designs
```
Parallel Group (most common Phase III):
R --> Treatment A --> Outcome assessment
R --> Treatment B --> Outcome assessment
Crossover:
R --> Treatment A --> Washout --> Treatment B --> Outcome
R --> Treatment B --> Washout --> Treatment A --> Outcome
Factorial (2x2):
R --> Drug A + Drug B
R --> Drug A + Placebo B
R --> Placebo A + Drug B
R --> Placebo A + Placebo B
Adaptive:
Stage 1: Enroll n1 patients --> Interim analysis
Stage 2: Modify design (dose, sample size, arm dropping) --> Continue
```
### Design Selection Criteria
| Factor | Recommended Design |
|--------|-------------------|
| Chronic disease, stable condition | Crossover (within-subject comparison) |
| Acute condition, one-time treatment | Parallel group |
| Multiple drugs to evaluate | Factorial or multi-arm |
| High uncertainty in effect size | Adaptive (sample size re-estimation) |
| Rare disease, limited patients | Bayesian adaptive, single-arm with historical control |
## Sample Size Calculation
### Two-Sample Comparison of Means
```python
from scipy.stats import norm
import numpy as np
def sample_size_two_means(delta: float, sigma: float,
alpha: float = 0.05, power: float = 0.80,
ratio: float = 1.0) -> dict:
"""
Sample size for comparing two group means (two-sided test).
delta: minimum clinically important difference
sigma: pooled standard deviation
alpha: type I error rate
power: desired power (1 - beta)
ratio: allocation ratio (n2/n1)
"""
z_alpha = norm.ppf(1 - alpha / 2)
z_beta = norm.ppf(power)
effect = delta / sigma
n1 = ((z_alpha + z_beta) ** 2 * (1 + 1 / ratio)) / effect ** 2
n2 = ratio * n1
return {
"n_per_group_1": int(np.ceil(n1)),
"n_per_group_2": int(np.ceil(n2)),
"total": int(np.ceil(n1) + np.ceil(n2)),
"effect_size": round(effect, 3),
}
# Example: detect 5-point difference, SD=15, 80% power
result = sample_size_two_means(delta=5, sigma=15)
print(f"Required: {result['total']} total patients")
```
### Sample Size for Survival Endpoints
```python
def sample_size_logrank(hazard_ratio: float, alpha: float = 0.05,
power: float = 0.80, ratio: float = 1.0,
median_control: float = 12.0,
accrual_time: float = 24.0,
followup_time: float = 12.0) -> dict:
"""
Sample size for log-rank test comparing two survival curves.
hazard_ratio: expected HR (treatment/control), <1 means treatment better
median_control: median survival in control arm (months)
"""
z_alpha = norm.ppf(1 - alpha / 2)
z_beta = norm.ppf(power)
# Required number of events (Schoenfeld formula)
d = ((z_alpha + z_beta) ** 2 * (1 + ratio) ** 2) / (
ratio * (np.log(hazard_ratio)) ** 2
)
d = int(np.ceil(d))
# Estimate probability of event during study
lambda_c = np.log(2) / median_control
lambda_t = lambda_c * hazard_ratio
# Average probability of event (simplified uniform accrual)
p_event_c = 1 - np.exp(-lambda_c * followup_time)
p_event_t = 1 - np.exp(-lambda_t * followup_time)
p_event_avg = (p_event_c + ratio * p_event_t) / (1 + ratio)
n_total = int(np.ceil(d / p_event_avg))
return {
"events_required": d,
"total_patients": n_total,
"hazard_ratio": hazard_ratio,
"p_event_avg": round(p_event_avg, 3),
}
```
## Randomization Methods
### Implementation
```python
import random
def stratified_block_randomization(strata: list[str],
block_sizes: list[int] = [4, 6],
ratio: tuple = (1, 1),
seed: int = 42) -> list[str]:
"""
Stratified permuted block randomization.
strata: list of stratum labels for each patient (in enrollment order)
block_sizes: list of possible block sizes (randomly selected)
ratio: allocation ratio (e.g., (1,1) for 1:1, (2,1) for 2:1)
Returns list of treatment assignments ('A' or 'B').
"""
rng = random.Random(seed)
stratum_queues = {}
assignments = []
for stratum in strata:
if stratum not in stratum_queues:
stratum_queues[stratum] = []
if not stratum_queues[stratum]:
# Generate new block
block_size = rng.choice(block_sizes)
n_a = block_size * ratio[0] // sum(ratio)
n_b = block_size - n_a
block = ["A"] * n_a + ["B"] * n_b
rng.shuffle(block)
stratum_queues[stratum] = block
assignments.append(stratum_queues[stratum].pop(0))
return assignments
```
## InteTrust audit
SAFEgrade B · trust 89/100 Nothing in the source contradicts what it says it does. Grade A is reserved for packages that have also passed the behavioural sandbox.
| Layer | What it checks | Result |
|---|---|---|
| L0 | Provenance & inventory | PASS |
| L1 | Static analysis of the code | NA |
| L2 | Instruction surface (what it tells the agent) | PASS |
| L3 | Class-specific surface | PASS |
| L4 | Behavioural (sandbox) | SKIPPED |
What the source does
- Filesystem
- none-observed
- Network
- none-observed
- Shell
- none-observed
- Dependencies
- pinned
- Secrets in source
- none-found
Findings (0)
No findings outside the package's declared scope.
Gates applied: no_behavioural_pass.
e1ba289846fdfull audit observations/trust-audit/skill/brycewang-stanford__clinical-trial-design-guide.json · Report an issue / request a re-scanAudit history
Every audit this skill has had.
| Date | Source | Verdict | Grade | Score | Change |
|---|---|---|---|---|---|
| 2026-10-08 | e1ba289846fd | SAFE | B | 89 | first audit |
Questions
What does the Clinical Trial Design Guide skill do?
🔬 A curated collection of 23,000+ agent skills for empirical research across 8 social science disciplines. | 精选 23,000+ AI Agent 技能库,覆盖8大社会科学学科的实证研究。CoPaper.AI 20分钟完成一篇可复现的规范实证论文,并支持用户上传 Skills。-- Maintained by CoPaper.AI from Stanford REAP.
Is Clinical Trial Design Guide safe to install?
The audit found nothing in the source that contradicts what it says it does, and graded it B (89/100). Grade A is held back for packages that have also passed a sandboxed behavioural run, which is why a clean skill reads B.
What can Clinical Trial Design Guide access on my machine?
The audit observed no filesystem, network or shell use at all in its source.
Which assistants does Clinical Trial Design Guide work with?
Its documentation mentions openclaw. That is what the text claims, not a compatibility test we ran.
How current is this page?
The grade is for one exact copy of the source (e1ba289846fd), read on 2026-10-08. The repository is watched, and a new audit runs when it changes — this is the first audit.